Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,177 | 1,884 | 3,047 | 4,315 | 1,918 |
| Receivables | N/A | N/A | 153 | 154 | 156 |
| Other current assets | 95 | 845 | 0 | 0 | 0 |
| TOTAL | $9,996 | $3,133 | $3,379 | $4,792 | $2,211 |
| Non-Current Assets | |||||
| PPE Net | 88 | 94 | 92 | 50 | 67 |
| Intangibles | 0 | 2,044 | 2,044 | 2,044 | 2,044 |
| Other Non-Current Assets | 459 | 563 | 657 | 698 | 737 |
| TOTAL | $547 | $2,701 | $2,793 | $2,792 | $2,848 |
| Total Assets | $10,543 | $5,834 | $6,172 | $7,584 | $5,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,550 | 1,875 | 958 | 1,319 | 1,275 |
| Accrued Expenses | 1,481 | 898 | 871 | 938 | 1,366 |
| Other current liabilities | 259 | 124 | 104 | 166 | 5,335 |
| TOTAL | $3,457 | $3,113 | $2,144 | $2,651 | $10,438 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 227 | 320 | 458 | 489 | 571 |
| TOTAL | $227 | $320 | $458 | $489 | $571 |
| Total Liabilities | $3,684 | $3,433 | $2,602 | $3,140 | $11,009 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,166 | 1,166 | 314 | 307 | 166 |
| Common Shares | 6 | 2 | 39 | 37 | 262 |
| Retained earnings | -251,142 | -245,636 | -244,126 | -242,885 | -239,738 |
| TOTAL | $6,859 | $2,401 | $3,570 | $4,444 | $-5,950 |
| Total Liabilities And Equity | $10,543 | $5,834 | $6,172 | $7,584 | $5,059 |